{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:36:19Z","timestamp":1762497379132,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.4158\/accr-2020-0225","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T10:51:45Z","timestamp":1596711105000},"page":"e286-e289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Eletriptan (Relpaxa\u2122) Causing False Positive Elevations In Urinary Metanephrines"],"prefix":"10.1016","volume":"6","author":[{"given":"Zachary W.","family":"Bloomer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh D.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed K.M.","family":"Shakir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/ACCR-2020-0225_bb0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jamcollsurg.2009.09.022","article-title":"Clinical spectrum of pheochromocytoma","volume":"209","author":"Guerrero","year":"2009","journal-title":"J Am Coll Surg"},{"key":"10.4158\/ACCR-2020-0225_bb0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-134-4-200102200-00016","article-title":"Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma","volume":"134","author":"Pacak","year":"2001","journal-title":"Ann intern Med"},{"key":"10.4158\/ACCR-2020-0225_bb0020","doi-asserted-by":"crossref","first-page":"101346","DOI":"10.1016\/j.beem.2019.101346","article-title":"Pheochromocytoma: an approach to diagnosis","volume":"34","author":"Sbardella","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2020-0225_bb0025","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA."},{"key":"10.4158\/ACCR-2020-0225_bb0030","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1210\/jc.2003-030720","article-title":"The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic Experience","volume":"88","author":"Kudva","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2020-0225_bb0035","first-page":"439","article-title":"Diagnostic performance of PET\/CT utilizing 68Ga-DOTATATE, 18F-FDG, 18F-DOPA, and 18F-FDA, and anatomic imaging in the detection of sporadic primary pheochromocytoma - A comparative prospective study","volume":"60","author":"Jha","year":"2019","journal-title":"J Nucl Med"},{"key":"10.4158\/ACCR-2020-0225_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-123-2-199507150-00004","article-title":"Plasma metanephrines in the diagnosis of pheochromocytoma","volume":"123","author":"Lenders","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.4158\/ACCR-2020-0225_bb0045","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2020-0225_bb0050","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2165\/00003495-200666080-00010","article-title":"Eletriptan: a review of its use in the acute treatment of migraine","volume":"66","author":"McCormack","year":"2006","journal-title":"Drugs"},{"key":"10.4158\/ACCR-2020-0225_bb0055","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1526-4610.2003.03044.x","article-title":"Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg","volume":"43","author":"Mathew","year":"2003","journal-title":"Headache"},{"key":"10.4158\/ACCR-2020-0225_bb0060","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1365-2265.2007.02805.x","article-title":"The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma","volume":"66","author":"Perry","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.4158\/ACCR-2020-0225_bb0065","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/cancers11040586","article-title":"Chromogranin A in the laboratory diagnosis of pheochromocytoma and paraganglioma","volume":"11","author":"Bilek","year":"2019","journal-title":"Cancers"},{"key":"10.4158\/ACCR-2020-0225_bb0070","unstructured":"PacakK, Del RiveroJ.Pheochromocytoma. Table 4, Drugs that may cause false positive elevations of plasma and urinary catecholamines or metanephrines. Endotext [Internet]. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK278970\/table\/pheochromocytoma.table4drug\/. Accessed January 1, 2020."},{"key":"10.4158\/ACCR-2020-0225_bb0075","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: Plasma versus urinary free or deconjugated O-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"key":"10.4158\/ACCR-2020-0225_bb0080","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1210\/jc.2009-0303","article-title":"Dietary influences on plasma and urinary meta-nephrines: implications for diagnosis of catecholamine-producing tumors","volume":"94","author":"de Jong","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2020-0225_bb0085","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/1756285616650619","article-title":"Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response","volume":"9","author":"Capi","year":"2016","journal-title":"Ther Adv Neurol Disord"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060520306349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060520306349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:31:28Z","timestamp":1762497088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060520306349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2376060520306349"],"URL":"https:\/\/doi.org\/10.4158\/accr-2020-0225","relation":{},"ISSN":["2376-0605"],"issn-type":[{"type":"print","value":"2376-0605"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eletriptan (Relpaxa\u2122) Causing False Positive Elevations In Urinary Metanephrines","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/ACCR-2020-0225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}